Results 1 to 10 of about 30,317 (268)
Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage [PDF]
Frontiers in Cellular and Infection Microbiology, 2023 Neisseria meningitidis causes invasive meningococcal disease (IMD), which is associated with significant mortality and long-term consequences, especially among young children.
Emilija Sereikaitė +10 more
doaj +2 more sources
Analysis of novel meningococcal vaccine formulations [PDF]
Human Vaccines & Immunotherapeutics, 2017 The protective effect of meningococcal vaccines targeting disease causing serogroups exemplified by the introduction of MenAfriVac™ in Africa, is well established and documented in large population-based studies.
Susu M. Zughaier
doaj +2 more sources
Relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt [PDF]
Human Vaccines & Immunotherapeutics, 2019 We described the relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt. Parent-child dyads that were eligible for both meningococcal and HPV vaccines participated in pre-visit surveys and ...
Terresa J. Eun +6 more
doaj +2 more sources
Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers [PDF]
Tropical Medicine and Infectious Disease, 2019 Background: Major intercontinental outbreaks of invasive meningococcal disease associated with the Hajj occurred in 1987, 2000, and 2001. Mandatory meningococcal vaccination for all pilgrims against serogroups A and C and, subsequently, A, C, W, and Y ...
Al-Mamoon Badahdah +10 more
doaj +2 more sources
Current status and challenges of meningococcal vaccines development in China
Zhongguo gonggong weisheng, 2022 Vaccination is the most effective and economical way to prevent meningococcal meningitis. In the past few decades, with widespread use of meningococcal vaccines, the incidence of meningococcal meningitis has dropped significantly. There are some vaccines
Ying-hua XU, Ya-nan LI, Qiang YE
doaj +1 more source
World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
Эпидемиология и вакцинопрофилактика, 2022 Relevance. The success of vaccine prophylaxis of meningococcal infection depends on the composition and properties of vaccine preparations and the strict implementation of recommendations on vaccine prophylaxis tactics by the territorial epidemiological ...
I. S. Koroleva, M. A. Koroleva
doaj +1 more source
BMC Public Health, 2023 Background Men who have sex with men (MSM) have suboptimal uptake of human papillomavirus (HPV) and meningococcal vaccines. This study examines barriers and facilitators to HPV and meningococcal vaccination among MSM in a large, racially/ethnically ...
Justin Naidu, Andrea N. Polonijo
doaj +1 more source
Effectiveness of meningococcal C conjugate vaccine in Salvador, Brazil: a case-control study. [PDF]
PLoS ONE, 2015 BACKGROUND:During a citywide epidemic of serogroup C meningococcal disease in Salvador in 2010, Brazil, the state government initiated mass vaccination targeting two age groups with high attack rates: individuals aged
Cristiane Wanderley Cardoso +4 more
doaj +1 more source
Development of group B meningococcal vaccine: a progress review
Zhongguo gonggong weisheng, 2022 Epidemic cerebrospinal meningitis is a respiratory infectious disease caused by Neisseria meningitidis, most commonly manifesting as meningitis and septicaemia.
Wei ZHAO, Shuang BAI, Yan-li KANG
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2022 Vaccination offers the best way to prevent invasive meningococcal disease (IMD). As demonstrated in countries with national immunization programs (NIPs) against IMD, meningococcal conjugate vaccines have contributed to significant declines in incidence ...
Gary S. Marshall +3 more
doaj +1 more source